Steward Partners Investment Advisory’s 89bio ETNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,860
Closed -$56.7K 4365
2025
Q3
$56.7K Sell
3,860
-21,707
-85% -$221K ﹤0.01% 2539
2025
Q2
$251K Buy
25,567
+4,807
+23% +$39.8K ﹤0.01% 1645
2025
Q1
$151K Buy
20,760
+550
+3% +$4.81K ﹤0.01% 1786
2024
Q4
$158K Sell
20,210
-60,150
-75% -$495K ﹤0.01% 1747
2024
Q3
$595K Buy
80,360
+23,775
+42% +$200K 0.01% 1039
2024
Q2
$453K Buy
56,585
+20,475
+57% +$183K ﹤0.01% 1101
2024
Q1
$420K Buy
+36,110
New +$400K ﹤0.01% 1130

Other funds holding ETNB

Steward Partners Investment Advisory's ETNB Position: Q4 2025 in Review

Steward Partners Investment Advisory sold out of 89bio (ETNB) in Q4 2025, closing a stake of 3,860 shares — an estimated $56.7K sold.

Steward Partners Investment Advisory first reported a position in ETNB in Q1 2024 and held it in 7 quarters. The position peaked at $595K in Q3 2024. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Steward Partners Investment Advisory reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 3,860 89bio shares in Q4 2025, an estimated $56.7K.
  • Steward Partners Investment Advisory first reported a position in 89bio in Q1 2024 and held it in 7 quarters.
  • Steward Partners Investment Advisory's 89bio position peaked at $595K in Q3 2024.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2025, filed 12 Feb 2026.